Pricing Log in Create free account

LB Pharmaceuticals Inc (LBRX) vs Syndax Pharmaceuticals, Inc. (SNDX)

LB Pharmaceuticals Inc and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Syndax Pharmaceuticals, Inc. are of similar size ($1.2B and $1.2B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −87.6%) and the lower return on invested capital (−1,304.8% vs −247.9%). Across the 13 metrics below, LB Pharmaceuticals Inc leads on 10 and Syndax Pharmaceuticals, Inc. on 3.

Valuation

Metric LBRX SNDX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.55 9.71
P/B 3.33 75.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 4.77 9.21
Earnings yield (9.36%) (19.49%) (33.15%)
Free cash flow yield (7.48%) (19.27%) (25.50%)

Profitability

Metric LBRX SNDX Biotechnology median
Gross margin — 95.78% 65.16%
Operating margin 0.00% (77.05%) 0.00%
Net margin 0.00% (87.60%) 0.00%
Free cash flow margin 0.00% (87.64%) 0.00%
Return on equity (72.07%) (255.93%) (56.36%)
Return on assets (47.38%) (33.97%) (48.04%)
Return on invested capital (1,304.79%) (247.93%) 0.00%

Growth

Metric LBRX SNDX Biotechnology median
Revenue growth (TTM) — 222.34% 6.02%
EPS growth (last fiscal year) 98.22% 11.56% 30.26%
Revenue growth, 5-year CAGR — 157.68% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX SNDX Biotechnology median
Debt to equity 0.00 38.95 0.00
Current ratio 15.08 6.77 4.72
Net debt to EBITDA 9.90 0.25 0.96

Dividend

Metric LBRX SNDX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LBRX SNDX Biotechnology median
Market cap 1.18b 1.22b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack